The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Calvepen 250 mg/5 ml Powder for Oral Suspension

Clonmel Healthcare LtdPA0126/137/003

Main Information

Trade NameCalvepen 250 mg/5 ml Powder for Oral Suspension
Dosage FormPowder for oral suspension
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/137/003

Group Information

ATC CodeJ01CE Beta-lactamase sensitive penicillins
J01CE02 phenoxymethylpenicillin


License statusAuthorised
Licence Issued20/01/1986
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back